EUVIMEDEUVIMED entdecken
Crossref

Medial prefrontal cortex neurotransmitter abnormalities in posttraumatic stress disorder with and without comorbidity to major depression

Kelley M Swanberg iD, Hetty Prinsen, Christopher L Averill, Leonardo Campos, Abhinav V Kurada, John H Krystal, Ismene L Petrakis, Lynnette A Averill, Douglas L Rothman iD, Chadi G Abdallah, Christoph Juchem

NMR in Biomedicine · 2024

DOI: 10.1002/nbm.5220 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NMR in Biomedicine, 2024. Verfasst von Kelley M Swanberg und 10 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Engineering, Columbia University School of Engineering and Applied Science, New York, NY, USA. Hauptthemen laut MEDLINE: Prefrontal Cortex, Major Depressive Disorder, Stress Disorders, Post-Traumatic, Neurotransmitter Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: VA National Center for PTSD Clinical Neurosciences Division, Columbia University, NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Posttraumatic stress disorder (PTSD) is a chronic psychiatric condition that follows exposure to a traumatic stressor. Though previous in vivo proton ( 1 H) MRS) research conducted at 4 T or lower has identified alterations in glutamate metabolism associated with PTSD predisposition and/or progression, no prior investigations have been conducted at higher field strength. In addition, earlier studies have not extensively addressed the impact of psychiatric comorbidities such as major depressive disorder (MDD) on PTSD‐associated 1 H‐MRS‐visible brain metabolite abnormalities. Here we employ 7 T 1 H MRS to examine concentrations of glutamate, glutamine, GABA, and glutathione in the medial prefrontal cortex (mPFC) of PTSD patients with MDD (PTSD+ MDD+ ; N = 6) or without MDD (PTSD+ MDD− ; N = 5), as well as trauma‐unmatched controls without PTSD but with MDD (PTSD− MDD+ ; N = 9) or without MDD (PTSD− MDD− ; N = 18). Participants with PTSD demonstrated decreased ratios of GABA to glutamine relative to healthy PTSD− MDD− controls but no single‐metabolite abnormalities. When comorbid MDD was considered, however, MDD but not PTSD diagnosis was significantly associated with increased mPFC glutamine concentration and decreased glutamate:glutamine ratio. In addition, all participants with PTSD and/or MDD collectively demonstrated decreased glutathione relative to healthy PTSD− MDD− controls. Despite limited findings in single metabolites, patterns of abnormality in prefrontal metabolite concentrations among individuals with PTSD and/or MDD enabled supervised classification to separate them from healthy controls with 80+% sensitivity and specificity, with glutathione, glutamine, and myoinositol consistently among the most informative metabolites for this classification. Our findings indicate that MDD can be an important factor in mPFC glutamate metabolism abnormalities observed using 1 H MRS in cohorts with PTSD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prefrontal CortexMajor Depressive DisorderStress Disorders, Post-TraumaticNeurotransmitter AgentsHumansMaleFemaleAdultComorbidityMiddle AgedGlutamineGlutamic AcidProton Magnetic Resonance Spectroscopygamma-Aminobutyric Acid

Stichwörter der Autor:innen

GABAglutamateglutaminein vivo proton MRSmajor depressive disordermedial prefrontal cortexposttraumatic stress disordersupervised machine learning

Substanzen

Neurotransmitter AgentsGlutamineGlutamic Acidgamma-Aminobutyric Acid

Autor:innen und Institutionen

  • Biomedical Engineering, Columbia University School of Engineering and Applied Science, New York, NY, USA.
  • Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT, USA.
  • Clinical Neuroscience Division, Department of Veterans Affairs, National Center for Posttraumatic Stress Disorder, Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA.
  • Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
  • Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, USA.
  • US Department of Veterans Affairs Michael E. DeBakey VA Medical Center, Houston, TX, USA.

ORCID-Profile: Kelley M Swanberg, Douglas L Rothman

Förderung

  • VA National Center for PTSD Clinical Neurosciences Division
  • Columbia University
  • NIMH NIH HHS
  • CSRD VA
  • Yale Center for Clinical Investigation
  • National Institute of Mental Health
  • Yale Center for Clinical Investigation, Yale School of Medicine

Zitieren

APA

Swanberg, K. M., Prinsen, H., Averill, C. L., Campos, L., Kurada, A. V., Krystal, J. H., Petrakis, I. L., Averill, L. A., Rothman, D. L., Abdallah, C. G., & Juchem, C. (2024). Medial prefrontal cortex neurotransmitter abnormalities in posttraumatic stress disorder with and without comorbidity to major depression. NMR in Biomedicine. https://doi.org/10.1002/nbm.5220

Vancouver

Swanberg KM, Prinsen H, Averill CL, Campos L, Kurada AV, Krystal JH, et al. Medial prefrontal cortex neurotransmitter abnormalities in posttraumatic stress disorder with and without comorbidity to major depression. NMR in Biomedicine. 2024. doi:10.1002/nbm.5220

BibTeX
@article{Swanberg2024,
  author = {Swanberg, Kelley M and Prinsen, Hetty and Averill, Christopher L and Campos, Leonardo and Kurada, Abhinav V and Krystal, John H and Petrakis, Ismene L and Averill, Lynnette A and Rothman, Douglas L and Abdallah, Chadi G and Juchem, Christoph},
  title = {Medial prefrontal cortex neurotransmitter abnormalities in posttraumatic stress disorder with and without comorbidity to major depression},
  journal = {NMR in Biomedicine},
  year = {2024},
  doi = {10.1002/nbm.5220}
}
Kostenlos starten →